Biotechnology and Development ApS: Financial statements 2017
CVR: 33870639
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 24,933 and a net result of DKK -2,821 compared with DKK 13,343 the year before. That is a decrease of 21.3% compared with the year before. Equity in the 2017 report amounted to DKK 14,551. The solvency ratio was 12.4%.
- Gross Profit
- DKK 24,933
- Profit/Loss
- DKK -2,821
- Equity
- DKK 14,551
- Total Assets
- DKK 117,821
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 25 t. | -3 t. | 15 t. | - |
| 2016 | - | 32 t. | 13 t. | 17 t. | - |
| 2015 | - | 14 t. | 10 t. | 4 t. | - |
| 2014 | - | -12 t. | -9 t. | -6 t. | - |
| 2013 | - | -6 t. | -4 t. | 3 t. | - |
Official annual report
Keep an eye on Biotechnology and Development ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. Equity in the 2025 report amounted to DKK 105,217.